1. Home
  2. GSK vs MDT Comparison

GSK vs MDT Comparison

Compare GSK & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSK plc (Each representing two)

GSK

GSK plc (Each representing two)

HOLD

Current Price

$51.51

Market Cap

108.7B

Sector

Health Care

ML Signal

HOLD

Logo Medtronic plc.

MDT

Medtronic plc.

HOLD

Current Price

$86.66

Market Cap

107.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSK
MDT
Founded
1715
1949
Country
United Kingdom
Ireland
Employees
66841
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7B
107.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
GSK
MDT
Price
$51.51
$86.66
Analyst Decision
Buy
Buy
Analyst Count
2
21
Target Price
N/A
$108.21
AVG Volume (30 Days)
4.4M
6.9M
Earning Date
04-29-2026
06-03-2026
Dividend Yield
3.40%
3.58%
EPS Growth
N/A
3.32
EPS
N/A
3.73
Revenue
N/A
$36,364,000,000.00
Revenue This Year
$6.99
$8.91
Revenue Next Year
$4.19
$6.54
P/E Ratio
$32.75
$23.24
Revenue Growth
N/A
8.43
52 Week Low
$36.75
$73.31
52 Week High
$61.70
$106.33

Technical Indicators

Market Signals
Indicator
GSK
MDT
Relative Strength Index (RSI) 46.89 61.01
Support Level $49.92 $85.35
Resistance Level $51.79 $89.01
Average True Range (ATR) 1.15 2.03
MACD 0.01 0.28
Stochastic Oscillator 24.22 73.10

Price Performance

Historical Comparison
GSK
MDT

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About MDT Medtronic plc.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Share on Social Networks: